Clinical Trial Update: Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age [Phase 3]

View source ↗

Summary

Phase 3 trial update of a pneumococcal conjugate vaccine in healthy infants aged 6 to 12 weeks; trial completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Streptococcus Pneumoniae Infections
• Streptococcus Pneumoniae Vaccines

Drugs mentioned

• Pneumococcal conjugate vaccine (pneumococcal conjugate vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal, Streptococcus Pneumoniae Vaccines | Phase 3 | Status: COMPLETED | Results posted: 2012-05-10